2021
Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19
Altibi A, Pallavi B, Liaqat H, Slota A, Sheth R, Al Jebbawi L, George M, LeDuc A, Abdallah E, Russell L, Jain S, Shirvanian N, Masri A, Kak V. Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19. Scientific Reports 2021, 11: 6488. PMID: 33753786, PMCID: PMC7985211, DOI: 10.1038/s41598-021-85916-w.Peer-Reviewed Original ResearchConceptsPrisoner statusNon-prisonersOutcomes of prisonersNon-prison populationIn-hospital mortalityIntensive care unitCOVID-19 patientsIncarcerated individualsClinical outcomesHospitalized prisonersPrisonPrimary outcomeCohort of hospitalized COVID-19 patientsCompare clinical outcomesElevated inflammatory markersHospitalized COVID-19 patientsRates of ICU admissionSevere clinical presentationCox regression modelsAssociated with more severe clinical presentationIn-hospital deathAssociated with higher in-hospital deathMultivariate logistic regressionHigher in-hospital deathCOVID-19
2017
BRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis
Vuong H, Altibi A, Duong U, Ngo H, Pham T, Fung K, Hassell L. BRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis. Molecular Neurobiology 2017, 55: 3718-3724. PMID: 28534272, DOI: 10.1007/s12035-017-0599-y.Peer-Reviewed Original ResearchConceptsProgression-free survivalKaplan Meier curveOverall survivalBRAF V600EPrognostic valueBRAF mutationsGlioma patientsImproved survivalData of hazard ratioHazard ratioYoung adult gliomasImproved overall survivalMeta-analysisInverse variance methodLow grade gliomasVirtual Health LibraryPrognosis of glioma patientsRandom-effects modelPrognostic impactPrognostic factorsTumor gradeFavorable prognosisPatient ageAdult gliomasPooled HR